Stellenwert von MAO-B-Inhibitoren und NMDA-Antagonisten in der Therapie des Morbus Parkinson
On the Role of MAO B Inhibitors and NMDA Antagonists in the Therapy of Parkinson's Disease

Erstveröffentlichung
2010Authors
Kassubek, Jan
Buettner, Theresa
Reichmann, Heinz
Riederer, Peter
Schulz, Jorg B.
Wissenschaftlicher Artikel
Published in
Fortschritte der Neurologie, Psychiatrie ; 78 (2010), 1. - S. S34-S36. - ISSN 0720-4299. - eISSN 1439-3522
Link to publication
https://dx.doi.org/10.1055/s-0029-1245166Institutions
UKU. Klinik für NeurologieSubject headings
[Free subject headings]: NMDA receptor antagonists | MAO B inhibitors | amantadine | memantine | selegiline | rasagiline | TRIAL[DDC subject group]: DDC 610 / Medicine & health